Nabiximols: Multiple Sclerosis

(asked on 14th January 2021) - View Source

Question to the Department of Health and Social Care:

To ask Her Majesty's Government what assessment they have made about the barriers to prescribing Sativex to treat spasticity in people with multiple sclerosis; and what plans they have to work with NHS England and organisations such as the MS Society to address any such barriers.


Answered by
Lord Bethell Portrait
Lord Bethell
This question was answered on 22nd January 2021

The Department has made no recent assessment. However, Departmental officials regularly engage with stakeholders and organisations such as the MS Society, to discuss a range of issues, including concerns relating to access to treatments.

Reticulating Splines